PROTEOFORM SCIENTIFIC IS NOW ALLUMIQS CORPORATION. NEW NAME, EXPANDED OMICS SOLUTIONS.

A company that moves at the speed of science.

COVID changed everything. Not only did it change the way most of us live and do business, but with the fastest novel vaccine development in history, it set a new bar for how quickly research could reasonably get to market. The research community is now moving at an unprecedented pace—fuelled by omics, mass spectrometry, and data analytics—and it needs a partner that can help them keep up with contemporary expectations.

A Canadian-based omics solutions provider, Allumiqs is dedicated to delivering solutions that elevate multiomics within research pathways and help our customers get to market faster.

Born when Proteoform Scientific joined forces with PhenoSwitch Bioscience in early 2022, Allumiqs brings together sample prep, mass spec solutions, and data analytics as an outsourced collaborator for biotech and biopharma researchers. Our platform helps customers solve time and throughput challenges around sample prep, access to omics expertise and mass spec solutions needed to advance their work, and see their research data in a whole new light.

Our Vision & Values

Our primary goal is to address the complex problems of omics research by providing cost-effective, efficient, and simple solutions that accelerate discovery and publication. We help our customers achieve this by:

  • Promoting the discovery and quantification of biomarkers for better diagnostics, leading to improved quality of life for patients
  • Reducing costs and time associated with R&D to accelerate product development and reduce time-to-market length
  • Providing the appropriate technology required to effectively identify, quantify, and characterize molecules in simple to very complex samples
  • Collaborating to develop new technologies meeting both general and specialized needs

Our Core Values

Collaboration

Simplicity

Transparency

Quality

Being Bold

Our Industry

We’re proud to be a bold innovator, sparking science discoveries that accelerate the pace of biotech and biopharma breakthroughs. And we’re equally proud to support industry associations in the omics, mass spectrometry, data analytics, and personalized medicine sectors by actively participating in their annual meetings, events, and learning opportunities. We look forward to meeting you face-to-face or virtually at an event in the near future.